AVAX Technologies, Inc. (OTC: AVXT)

AVAX Technologies, Inc. (OTC:AVXT) is a biotech that is currently (or was) focused on developing and commercializing its AC Vaccine technology for the treatment of cancer. It's leading drug in the pipeline is (or was) MVax and supposedly in a Phase III Registration trial.

But the company has not issued any recent news or updates. Many of the links on their website do not work and they do seem to respond to inquiries. It doesn't look like the company has issued a press release in over a year. The last news to come from the company was an EDGAR filing back in May.

I have tried to contact the company:

December 3: Sent an email to John Prendergast, Chairman of the Board of AVAX about the non-working links and lack of news from the company. No response so far.

November 12?: The web site has not been updated. I called the main number again a few times and could not reach a live person. I left a voice mail of their Quality Assurance guy (couldn't catch his name) and asked him or someone else to call me back about the website and lack of news. No response.

November 4: Called the main number at 215-241-9760. The woman who answered said they were "working on" the non-working links on their site. I wish now I had called from my home instead of from the store. Could have have a had a longer conservation in peace.

Here's a link to a post on November 4th I wrote about AVXT on this.

At the moment, I will continue to hold on to my AVXT shares but I don't think I'll buy more until the company provides an update or if there any significant news from a news source. I'm just not feeling very confident about AVXT at the moment but that doesn't mean things can suddenly change. All it would take is one new release from the company with positive news or an update from the FDA.

By the way here's an optimistic item on AVXT that StocksHaven published a couple of months ago.

Here's a direct link to the entire text.